Skip to main content
PMC home page
Journal of Virology logoLink to Journal of Virology
. 1984 Aug;51(2):445–451. doi: 10.1128/jvi.51.2.445-451.1984

Neutralization of Newcastle disease virus by monoclonal antibodies to the hemagglutinin-neuraminidase glycoprotein: requirement for antibodies to four sites for complete neutralization.

R M Iorio, M A Bratt
PMCID: PMC254458  PMID: 6205169

Abstract

The neutralizing characteristics of monoclonal antibodies directed to four antigenic sites on the hemagglutinin-neuraminidase glycoprotein of Newcastle disease virus were determined. Neutralization by each antibody resulted in a persistent fraction of nonneutralized virus which varied from 1 to 17% depending on the hemagglutinin-neuraminidase site recognized, but not on the antibody. The addition of antibodies to all four sites on the hemagglutinin-neuraminidase glycoprotein was required to give a level of neutralization comparable with that obtained with polyclonal mouse antiserum. The high persistent fractions were not due to viral aggregates, a high level of variants in the virus stock, the use of insufficient antibody, low antibody avidity, or an effect peculiar to the use of the chicken cells as host. The addition of rabbit anti-mouse immunoglobulin to the persistent fraction left by any of the antibodies resulted in a further reduction in infectivity, often by as much as two logs. Thus, some viral particles are capable of binding antibody while retaining their infectivity. The implications of these findings to the mechanism of neutralization are discussed.

Full text

PDF
449

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ashe W. K., Notkins A. L. Neutralization of an infectious herpes simplex virus-antibody complex by anti-gamma-globulin. Proc Natl Acad Sci U S A. 1966 Aug;56(2):447–451. doi: 10.1073/pnas.56.2.447. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. BRADISH C. J., FARLEY J. O., FERRIER H. E. Studies on the nature of the nature of the neutralization reaction and the competition for neutralizing antibody between components of the virus system of foot-and-mouth disease. Virology. 1962 Nov;18:378–400. doi: 10.1016/0042-6822(62)90029-6. [DOI] [PubMed] [Google Scholar]
  3. Bratt M. A., Gallaher W. R. Preliminary analysis of the requirements for fusion from within and fusion from without by Newcastle disease virus. Proc Natl Acad Sci U S A. 1969 Oct;64(2):536–543. doi: 10.1073/pnas.64.2.536. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Chanas A. C., Gould E. A., Clegg J. C., Varma M. G. Monoclonal antibodies to Sindbis virus glycoprotein E1 can neutralize, enhance infectivity, and independently inhibit haemagglutination or haemolysis. J Gen Virol. 1982 Jan;58(Pt 1):37–46. doi: 10.1099/0022-1317-58-1-37. [DOI] [PubMed] [Google Scholar]
  5. Clavell L. A., Bratt M. A. Hemolytic interaction of Newcastle disease virus and chicken erythrocytes. II. Determining factors. Appl Microbiol. 1972 Mar;23(3):461–470. doi: 10.1128/am.23.3.461-470.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Della-Porta A. J., Westaway E. G. A multi-hit model for the neutralization of animal viruses. J Gen Virol. 1978 Jan;38(1):1–19. doi: 10.1099/0022-1317-38-1-1. [DOI] [PubMed] [Google Scholar]
  7. Dimmock N. J. Review article initial stages in infection with animal viruses. J Gen Virol. 1982 Mar;59(Pt 1):1–22. doi: 10.1099/0022-1317-59-1-1. [DOI] [PubMed] [Google Scholar]
  8. Ey P. L., Prowse S. J., Jenkin C. R. Isolation of pure IgG1, IgG2a and IgG2b immunoglobulins from mouse serum using protein A-sepharose. Immunochemistry. 1978 Jul;15(7):429–436. doi: 10.1016/0161-5890(78)90070-6. [DOI] [PubMed] [Google Scholar]
  9. GRANOFF A. Studies on mixed infection with Newcastle disease virus. II. The occurrence of Newcastle disease virus heterozygotes and study of phenotypic mixing involving serotype and thermal stability. Virology. 1959 Dec;9:649–670. doi: 10.1016/0042-6822(59)90155-2. [DOI] [PubMed] [Google Scholar]
  10. GRANOFF A. THE INTERACTION OF NEWCASTLE DISEASE VIRUS AND NEUTRALIZING ANTIBODY. Virology. 1965 Jan;25:38–47. doi: 10.1016/0042-6822(65)90249-7. [DOI] [PubMed] [Google Scholar]
  11. Hahon N. Neutralization of residual infectivity of Venezuelan equine encephalomyelitis virus by anti-gamma globulin. J Gen Virol. 1970 Mar;6(3):361–372. doi: 10.1099/0022-1317-6-3-361. [DOI] [PubMed] [Google Scholar]
  12. Hightower L. E., Bratt M. A. Protein synthesis in Newcastle disease virus-infected chicken embryo cells. J Virol. 1974 Apr;13(4):788–800. doi: 10.1128/jvi.13.4.788-800.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Icenogle J., Shiwen H., Duke G., Gilbert S., Rueckert R., Anderegg J. Neutralization of poliovirus by a monoclonal antibody: kinetics and stoichiometry. Virology. 1983 Jun;127(2):412–425. doi: 10.1016/0042-6822(83)90154-x. [DOI] [PubMed] [Google Scholar]
  14. Iorio R. M., Bratt M. A. Monoclonal antibodies to newcastle disease virus: delineation of four epitopes on the HN glycoprotein. J Virol. 1983 Nov;48(2):440–450. doi: 10.1128/jvi.48.2.440-450.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Kliks S. C., Halstead S. B. An explanation for enhanced virus plaque formation in chick embryo cells. Nature. 1980 Jun 12;285(5765):504–505. doi: 10.1038/285504a0. [DOI] [PubMed] [Google Scholar]
  16. Köhler G., Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature. 1975 Aug 7;256(5517):495–497. doi: 10.1038/256495a0. [DOI] [PubMed] [Google Scholar]
  17. LAFFERTY K. J. THE INTERACTION BETWEEN VIRUS AND ANTIBODY. I. KINETIC STUDIES. Virology. 1963 Sep;21:61–75. doi: 10.1016/0042-6822(63)90305-2. [DOI] [PubMed] [Google Scholar]
  18. Mandel B. Neutralization of animal viruses. Adv Virus Res. 1978;23:205–268. doi: 10.1016/S0065-3527(08)60101-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Mandel B. Neutralization of poliovirus: a hypothesis to explain the mechanism and the one-hit character of the neutralization reaction. Virology. 1976 Feb;69(2):500–510. doi: 10.1016/0042-6822(76)90480-3. [DOI] [PubMed] [Google Scholar]
  20. Merz D. C., Scheid A., Choppin P. W. Importance of antibodies to the fusion glycoprotein of paramyxoviruses in the prevention of spread of infection. J Exp Med. 1980 Feb 1;151(2):275–288. doi: 10.1084/jem.151.2.275. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Morrison T. G. Site of synthesis of membrane and nonmembrane proteins of vesicular stomatitis virus. J Biol Chem. 1975 Sep 10;250(17):6955–6962. [PubMed] [Google Scholar]
  22. Peiris J. S., Porterfield J. S., Roehrig J. T. Monoclonal antibodies against the flavivirus West Nile. J Gen Virol. 1982 Feb;58(Pt 2):283–289. doi: 10.1099/0022-1317-58-2-283. [DOI] [PubMed] [Google Scholar]
  23. RUBIN H., FRANKLIN R. M. On the mechanism of Newcastle disease virus neutralization by immune serum. Virology. 1957 Feb;3(1):84–95. doi: 10.1016/0042-6822(57)90025-9. [DOI] [PubMed] [Google Scholar]
  24. RUBIN H. Interactions between Newcastle disease virus (NDV), antibody and cell. Virology. 1957 Dec;4(3):533–562. doi: 10.1016/0042-6822(57)90085-5. [DOI] [PubMed] [Google Scholar]
  25. Svehag S. E. Formation and dissociation of virus-antibody complexes with special reference to the neutralization process. Prog Med Virol. 1968;10:1–63. [PubMed] [Google Scholar]
  26. Wallis C., Melnick J. L. Herpesvirus neutralization: induction of the persistent fraction by insufficient antibody. Virology. 1970 Sep;42(1):128–137. doi: 10.1016/0042-6822(70)90245-x. [DOI] [PubMed] [Google Scholar]
  27. Weiss S. R., Bratt M. A. Polyadenylate sequences on Newcastle disease virus mRNA synthesized in vivo and in vitro. J Virol. 1974 Jun;13(6):1220–1230. doi: 10.1128/jvi.13.6.1220-1230.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Welsh R. M. Host cell modification of lymphocytic choriomeningitis virus and Newcastle disease virus altering viral inactivation by human complement. J Immunol. 1977 Jan;118(1):348–354. [PubMed] [Google Scholar]
  29. Yewdell J., Gerhard W. Delineation of four antigenic sites on a paramyxovirus glycoprotein via which monoclonal antibodies mediate distinct antiviral activities. J Immunol. 1982 Jun;128(6):2670–2675. [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES